We offer systems for automated oligonucleotide synthesis at a range of scales supporting easy process development, optimization, scale up and transfer, reducing time to your next milestone.
Our oligonucleotide synthesizers are the result of more than 30 years of collaboration with leading oligonucleotide pharma. The goal is to design synthesizers that support a robust and reliable oligonucleotide process and transfer with high yield and quality.
We would like to hear your feedback and give you early access to the latest information on our oligonucleotide synthesis journey.
This includes news on our newly launched synthesizer, OligoPilot™, designed to produce oligonucleotides for early to mid-clinical trials, and on our upcoming system, ÄKTA oligosynt™, targeting small-scale synthesis and process development.